These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26139786)

  • 21. Summaries for patients. Does hepatitis B vaccination protection continue after 15 years?
    Ann Intern Med; 2005 Mar; 142(5):I34. PubMed ID: 15738447
    [No Abstract]   [Full Text] [Related]  

  • 22. Non-responders to hepatitis B vaccination: a review.
    Kubba AK; Taylor P; Graneek B; Strobel S
    Commun Dis Public Health; 2003 Jun; 6(2):106-12. PubMed ID: 12889288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus (HBV) infection and multiple sclerosis: One more reason to undergo vaccination?
    Mormile R
    Immunol Lett; 2015 May; 165(1):60-1. PubMed ID: 25794632
    [No Abstract]   [Full Text] [Related]  

  • 24. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occult hepatitis B infection among individuals belonging to the aboriginal Nicobarese tribe of India.
    Bhattacharya H; Bhattacharya D; Roy S; Sugunan AP
    J Infect Dev Ctries; 2014 Dec; 8(12):1630-5. PubMed ID: 25500663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early acute hepatitis B infection and hepatitis B vaccination in blood donors.
    Salker R; Howell DR; Moore MC; Kitchen AD
    Transfus Med; 2001 Dec; 11(6):463. PubMed ID: 11851946
    [No Abstract]   [Full Text] [Related]  

  • 27. Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination.
    Straten PT; Andersen MH
    Vaccine; 2011 May; 29(21):3728. PubMed ID: 21420415
    [No Abstract]   [Full Text] [Related]  

  • 28. Recombivax-HB: perspectives past, present and future.
    Venters C; Graham W; Cassidy W
    Expert Rev Vaccines; 2004 Apr; 3(2):119-29. PubMed ID: 15056038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
    Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
    Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprotection after hepatitis B vaccination in children aged 1 to 15 years in central province of Iran, Semnan.
    Rezaei M; Nooripoor S; Ghorbani R; Ramezanshams F; Mamishi S; Mahmoudi S
    J Prev Med Hyg; 2014 Mar; 55(1):1-3. PubMed ID: 25916024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation.
    Posuwan N; Wanlapakorn N; Sa-Nguanmoo P; Wasitthankasem R; Vichaiwattana P; Klinfueng S; Vuthitanachot V; Sae-Lao S; Foonoi M; Fakthongyoo A; Makaroon J; Srisingh K; Asawarachun D; Owatanapanich S; Wutthiratkowit N; Tohtubtiang K; Yoocharoen P; Vongpunsawad S; Poovorawan Y
    PLoS One; 2016; 11(3):e0150499. PubMed ID: 26938736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus seroprevalence among parturients in Accra, Ghana.
    Damale NK; Lassey AT; Bekoe V
    Int J Gynaecol Obstet; 2005 Sep; 90(3):240-1. PubMed ID: 16005878
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccination against hepatitis B among prisoners in Iran: accelerated vs. classic vaccination.
    Asli AA; Moghadami M; Zamiri N; Tolide-Ei HR; Heydari ST; Alavian SM; Lankarani KB
    Health Policy; 2011 May; 100(2-3):297-304. PubMed ID: 21269722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined immunization against hepatitis B: five-year follow-up.
    Rodgers A
    Pediatr Infect Dis J; 1993 Nov; 12(11):968. PubMed ID: 8265299
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis B Vaccination Induces Mucosal Antibody Responses in the Female Genital Tract, Indicating Potential Mechanisms of Protection Against Infection.
    Simpson SJ; Wiggins R; Fox JM; Mthethwa J; Cai C; Lacey CJN
    Sex Transm Dis; 2019 May; 46(5):e53-e56. PubMed ID: 30444798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria.
    Odusanya OO; Alufohai FE; Meurice FP; Wellens R; Weil J; Ahonkhai VI
    Int J Infect Dis; 2005 May; 9(3):139-43. PubMed ID: 15840454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B vaccination in pregnancy.
    Wood N; Isaacs D
    Expert Rev Vaccines; 2012 Feb; 11(2):125-7. PubMed ID: 22309660
    [No Abstract]   [Full Text] [Related]  

  • 38. The comparison of antibody response to different hepatitis b vaccines with and without pre-S2 antigen in children with cancer.
    Emir S; Büyükpamuk M; Akyüz C; Kutluk T; Güler E; Cağlar K
    Pediatr Hematol Oncol; 2002 Jun; 19(4):227-33. PubMed ID: 12051588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon.
    Braga WS; Castilho Mda C; Borges FG; Martinho AC; Rodrigues IS; Azevedo EP; Scazufca M; Menezes PR
    Rev Soc Bras Med Trop; 2012 Feb; 45(1):13-7. PubMed ID: 22370822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatitis B vaccine in patients with human immunodeficiency virus infection].
    Ramírez O CA; Fernández A DG; Valderrama B SL; Gómez Q CH; Támara R JR; Alvarez M CA
    Rev Chilena Infectol; 2009 Feb; 26(1):26-33. PubMed ID: 19350156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.